Table 1. Comparison of baseline characteristics between the test group and control group.
| Parameter | Control group (n = 139) | Test group (n = 141) | P - value |
|---|---|---|---|
| Anthropometric indicators | |||
| Age (y) | 57.94 ± 5.71 | 56.68 ± 5.33 | 0.068 |
| Height (cm) | 172.00 ± 7.54 | 171.50 ± 6.15 | 0.555 |
| Weight (kg) | 75.90 ± 10.63 | 76.74 ± 9.88 | 0.511 |
| BMI (kg/m2) | 25.59 ± 2.58 | 26.04 ± 2.66 | 0.167 |
| Abdominal Circumference (cm) | 93.05 ± 9.41 | 94.14 ± 8.58 | 0.329 |
| SBP (mmHg) | 119.50 ± 13.72 | 121.92 ± 14.80 | 0.172 |
| DBP (mmHg) | 78.08 ± 9.09 | 79.65 ± 9.10 | 0.165 |
| FLI | 49.70 ± 23.09 | 51.43 ± 21.99 | 0.536 |
| NAFLD Fibrosis Score | −23.80 ± 2.25 | −24.18 ± 2.37 | 0.194 |
| Liver Dysfunction | |||
| ALT (U/L) | 30.38 ± 23.00 | 28.65 ± 16.58 | 0.487 |
| AST (U/L) | 23.12 ± 12.96 | 22.15 ± 7.29 | 0.462 |
| GGT (mmol/L) | 39.59 ± 34.07 | 36.28 ± 22.57 | 0.356 |
| Lipid profile | |||
| TCH (mmol/L) | 5.08 ± 0.79 | 5.19 ± 0.82 | 0.258 |
| LDL-C (mmol/L) | 3.20 ± 0.72 | 3.33 ± 0.76 | 0.158 |
| HDL-C (mmol/L) | 0.89 ± 0.17 | 0.93 ± 0.19 | 0.092 |
| TG (mmol/L) | 2.06 ± 1.18 | 1.91 ± 0.91 | 0.240 |
| Insulin resistance | |||
| FPG (mmol/L) | 4.87 ± 1.17 | 5.00 ± 1.14 | 0.356 |
| Liver steatosis grade | |||
| Grade 0 n (%) | 0 (0%) | 0 (0%) | |
| Grade 1 n (%) | 72 (55.4%) | 58 (44.6%) | 0.100 |
| Grade 2 n (%) | 16 (12.3%) | 20 (15.4%) | |
| Grade 3 n (%) | 42 (32.3%) | 52 (40.0%) | |
FLI = fatty liver index, NAFLD-FS = NAFLD-fibrosis score, BMI = body mass index, SBP = systolic blood pressure, DBP = diastolic blood pressure, ALT = alanine aminotransferase, AST = aspartate aminotransferase, GGT = gamma-glutamine transpeptidase, TCH = total cholesterol, TG = triglyceride, LDL-C = low-density lipoprotein cholesterol, HDL-C = high-density lipoprotein cholesterol, FPG = fasting plasma glucose.